Day: April 6, 2020

TORONTO, April 06, 2020 (GLOBE NEWSWIRE) — Just Energy Group Inc. (“Just Energy” or the “Company”) (TSX:JE) (NYSE:JE) announced today that it will hold its annual and special meeting of shareholders (the “Meeting”) on August 11, 2020.  The meeting will deal with normal course matters, matters related to the requisition for a special meeting of shareholders received by Robert L. Snyder Trust – 2005 Stream (“Snyder”) and any other necessary business.  The date selected reflects the impact of the ongoing COVID-19 pandemic, associated restrictions on public gatherings, and the difficulties in holding a potentially contested virtual-only meeting in Canada.Shareholders will receive detailed information about the matters presented at the Meeting and how to vote in a management information circular in advance of August 11, 2020. Shareholders...

VANCOUVER, British Columbia, April 06, 2020 (GLOBE NEWSWIRE) — Novo Resources Corp. (“Novo” or the “Company”) (TSX-V: NVO; OTCQX: NSRPF) is pleased to announce that it has completed its subscription for 9,090,909 units (each a “GBM Unit”) of ASX-listed GBM Resources Limited (ASX: GBZ) (“GBM”). The GBM Units were paid for by the issuance of 197,907 common shares of Novo which are subject to a statutory hold period expiring on August 6, 2020.Each GBM Unit is comprised of one ordinary share of GBM and one-half of one ordinary share purchase warrant (each a “GBM Warrant”). Each of the 4,545,545 GBM Warrants entitles Novo to purchase one ordinary share of GBM at AUD $0.11 until April 6, 2023. Following the issuance of the GBM Units, Novo owns approximately 4.13% of the issued and outstanding ordinary shares of GBM.Novo has also been...

VANCOUVER, British Columbia, April 06, 2020 (GLOBE NEWSWIRE) — Diversified Royalty Corp. (TSX: DIV and DIV.DB) (the “Corporation” or “DIV”) is pleased to announce that its board of directors has approved a cash dividend of $0.01667 per common share for the period of April 1, 2020 to April 30, 2020, which is equal to $0.20 per common share on an annualized basis. The dividend will be paid on April 30, 2020 to shareholders of record on April 15, 2020.Q1 2020 Earnings Release DateDIV will release earnings results for the three months ended March 31, 2020 following the closing of regular trading on the Toronto Stock Exchange on May 14, 2020.Annual and Special MeetingThe Corporation will be holding its Annual and Special Meeting of shareholders at 1:00 pm (Pacific time) on Thursday, May 14, 2020 (the “Meeting”). In order to ensure the...

LAFAYETTE, La., April 06, 2020 (GLOBE NEWSWIRE) — Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it is increasing its previously issued net revenue guidance for the first quarter of 2020.  In addition, the Company is providing an update on current operations and response to the growing number of COVID-19 cases around the country.As previously disclosed, in response to the COVID-19 virus, the Company began modifying its clinical protocols to limit unnecessary patient encounters in order to ensure the safety of its employees as well as the safety of its patients. At this time, these measures do not appear to be negatively impacting the Company’s patient attrition rate. ...

Sanofi finalizes Praluent® (alirocumab) restructuring with RegeneronParis – April 6, 2020 – Sanofi has finalized the planned restructuring related to Praluent® (alirocumab) with Regeneron Pharmaceuticals, Inc.Effective April 1, 2020, Sanofi will have sole responsibility for Praluent outside the U.S. Regeneron will have sole responsibility for Praluent in the U.S. The restructuring simplifies the antibody collaboration between the companies, increases efficiency, and streamlines operations for Praluent.Although each company will have responsibility for supplying Praluent in its respective territory, the companies have entered into agreements to support manufacturing needs in the near term.Sanofi announced its intent to restructure the antibody collaboration for Praluent and Kevzara® (sarilumab) in December 2019. Sanofi continues to work...

Sanofi finalise la restructuration de l’accord relatif à Praluent® (alirocumab) avec RegeneronParis – Le 6 avril 2020 – Sanofi a finalisé le projet de restructuration lié à Praluent® (alirocumab) avec Regeneron Pharmaceuticals, Inc.À compter du 1er avril 2020, Sanofi aura l’entière responsabilité de Praluent en dehors des États-Unis et Regeneron l’entière responsabilité de Praluent aux États-Unis. Cette restructuration simplifie la collaboration sur les anticorps entre les deux entreprises, augmente l’efficacité et rationalise les opérations relatives à Praluent.Bien que chaque entreprise ait la responsabilité de distribuer Praluent sur son territoire respectif, Sanofi et Regeneron ont conclu des accords pour répondre aux besoins de fabrication à court terme.Sanofi a annoncé son intention de restructurer la collaboration sur les...

SPRINGDALE, Ark., April 06, 2020 (GLOBE NEWSWIRE) — Tyson Foods, Inc. (NYSE: TSN) will hold its second quarter 2020 earnings call Monday, May 4 at 9 a.m. Eastern. We encourage participants to pre-register for the conference call using the following link: http://dpregister.com/10140911. Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the operator. Participants may pre-register at any time, up to and including after the call has started. Those without internet access or who are unable to pre-register may dial in by calling:To listen to the live webcast, an archived replay or to view the accompanying slides, go to the company’s investor website at http://ir.tyson.com. The webcast also can be access by using the direct link https://event.on24.com/wcc/r/2159378/7239BF68E396E50F4A8EA0613FA51B16.A...